January 01, 2018 - MM&M - Medical Marketing and Media

Print Issue: January 01, 2018

Should pharma fear ICER?

The group’s reports, received with great interest by insurers and the Department of Veteran Affairs, have concluded certain high-profile drugs aren’t worth the cost. Pharma still hasn’t decided whether ICER is friend or foe.